Stocks
Pfizer (PFE) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 2.24 | 1.98 | 0.19 | 0.30 | 6.52 | 2.64 | |||
| Changes by years, y/y, % | +114% | -12% | -90% | +54% | +2 105% | +44.2% | |||
Pfizer. Debt/EBITDA
Pfizer. Debt/EBITDA, changes, %
Pfizer (PFE) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q4 | 2024Q1 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| Debt/EBITDA | -35.2 | -2.03 | 9.69 | 25.9 | 7.96 | 2.64 | ||
| Changes by years, y/y, % | -2 293% | -200% | +379% | +360% | -145% | |||
| Changes by quarters, q/q, % | +99% | -94% | -577% | +168% | -69% | |||
